Skip Navigation


NDT Advance Access originally published online on February 19, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow An erratum has been published
Right arrow All Versions of this Article:
19/5/1123    most recent
gfh099v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pan, X.
Right arrow Articles by Chen, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pan, X.
Right arrow Articles by Chen, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2004) 19: 1123-1128
Nephrol Dial Transplant Vol. 19 No. 5 © ERA-EDTA 2004; all rights reserved

Original Article

Detection of COL4A5 gene mutations in Chinese patients with Alport's syndrome

Xiaoxia Pan, Jingyin Yan, Hong Ren, Wen Zhang, Hao Shi, Haijin Yu, Chaohui Wang, Cuilan Hao, Xiaonong Chen and Nan Chen

Department of Nephrology, Ruijin Hospital, Shanghai Second Medical University, Shanghai, People's Republic of China

Correspondence and offprint requests to: Nan Chen, Department of Nephrology, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, People's Republic of China. Email: chennan_rj{at}yahoo.com.cn

Background. Mutations in the COL4A5 gene, encoding the {alpha}5 chain of type IV collagen, are responsible for X-linked Alport's syndrome (XLAS), a progressive nephropathy characterized by glomerular basement membrane abnormalities and usually associated with progressive hearing loss and ocular lesions.

Methods. In this study, we analysed all 51 exons of the COL4A5 gene in 20 Chinese patients with XLAS or suspected XLAS from 16 families by using polymerase chain reaction (PCR)–denaturing gradient gel electrophoresis (DGGE) DNA sequencing.

Results. Five gene mutations identified in five families were considered to be pathogenic, including one nonsense mutation in exon 1 (266C->T, Gln22Term), two missense mutations in exons 31 (2757G->T, Gly852Val) and 43 (4142C->T, Pro1314Ser), and two splice site mutations in introns 1 and 25 just next to the 3' end of their respective exons (283+1G->T, 2150+1G->T). According to GenBank, these five mutations have not been reported previously. All male patients have typical clinical manifestations and pathological findings that closely correspond to the effects of the mutations. Furthermore, seven gene polymorphisms were detected in introns 18 and 10 and exons 20, 27, 29, 39 and 46. Only the substitution in intron 18 (1234+25G->A) had a gene frequency significantly higher in patients than in normal individuals.

Conclusion. Our study demonstrated the critical role of COL4A5 gene mutations in the pathogenesis of XLAS. The linkage of the polymorphism to AS is still unknown.

Keywords: Alport's syndrome; COL4A5gene; gene polymorphism; type IV collagen


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.